Concert Pharmaceuticals Reports 2021 Financial Results and Provides Company Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall St futures kick off September under pressure as yields, oil prices rise
- Oil up around 2% as renewed US-Iran strikes stoke supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- The Warsh pivot markets didn't expect
- Oil settles up by more than 2.5% as US and Iran resume military attacks
Concert Pharma (CNCE) Misses Q4 EPS by 28c
March 3, 2022 6:09 AM ESTConcert Pharma (NASDAQ: CNCE) reported Q4 EPS of ($1.01), $0.28 worse than the analyst estimate of ($0.73). Revenue for the quarter came in at $13 thousand versus the consensus estimate of $20 thousand.
For earnings history and earnings-related data on Concert Pharma (CNCE) click here.
... More